These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21246350)

  • 1. Adverse drug events in an intensive care unit of a university hospital.
    Reis AM; Cassiani SH
    Eur J Clin Pharmacol; 2011 Jun; 67(6):625-32. PubMed ID: 21246350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.
    Carayon P; Wetterneck TB; Cartmill R; Blosky MA; Brown R; Kim R; Kukreja S; Johnson M; Paris B; Wood KE; Walker J
    BMJ Qual Saf; 2014 Jan; 23(1):56-65. PubMed ID: 24050986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of adverse drug events on morbidity and mortality in intensive care units: the JADE study.
    Ohta Y; Sakuma M; Koike K; Bates DW; Morimoto T
    Int J Qual Health Care; 2014 Dec; 26(6):573-8. PubMed ID: 25192926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study.
    Aljadhey H; Mahmoud MA; Ahmed Y; Sultana R; Zouein S; Alshanawani S; Mayet A; Alshaikh MK; Kalagi N; Al Tawil E; El Kinge AR; Arwadi A; Alyahya M; Murray MD; Bates D
    BMJ Open; 2016 Jul; 6(7):e010831. PubMed ID: 27406640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
    Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
    PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit.
    Kane-Gill S; Rea RS; Verrico MM; Weber RJ
    Am J Health Syst Pharm; 2006 Oct; 63(19):1876-81. PubMed ID: 16990635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.
    Sevilla-Sanchez D; Molist-Brunet N; Amblàs-Novellas J; Roura-Poch P; Espaulella-Panicot J; Codina-Jané C
    Eur J Clin Pharmacol; 2017 Jan; 73(1):79-89. PubMed ID: 27704168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug events identified by triggers at a teaching hospital in Brazil.
    Giordani F; Rozenfeld S; Martins M
    BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
    Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
    Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study.
    Klopotowska JE; Leopold JH; Bakker T; Yasrebi-de Kom I; Engelaer FM; de Jonge E; Haspels-Hogervorst EK; van den Bergh WM; Renes MH; Jong BT; Kieft H; Wieringa A; Hendriks S; Lau C; van Bree SHW; Lammers HJW; Wierenga PC; Bosman RJ; de Jong VM; Slijkhuis M; Franssen EJF; Vermeijden WJ; Masselink J; Purmer IM; Bosma LE; Hoeksema M; Wesselink E; de Lange DW; de Keizer NF; Dongelmans DA; Abu-Hanna A
    Br J Clin Pharmacol; 2024 Jan; 90(1):164-175. PubMed ID: 37567767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries.
    Anthes AM; Harinstein LM; Smithburger PL; Seybert AL; Kane-Gill SL
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):510-6. PubMed ID: 23440931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study.
    Eshetie TC; Hailemeskel B; Mekonnen N; Paulos G; Mekonnen AB; Girma T
    BMC Pediatr; 2015 Jul; 15():83. PubMed ID: 26173560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic.
    Maříková M; Očovská Z; Nerad V; Kuběna AA; Blaha V; Vlček J
    Int J Clin Pharm; 2021 Oct; 43(5):1218-1226. PubMed ID: 33763812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug events in critically ill patients with cancer: incidence, characteristics, and outcomes.
    Nazer LH; Hawari F; Al-Najjar T
    J Pharm Pract; 2014 Apr; 27(2):208-13. PubMed ID: 24319079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of risk factors for adverse drug events in a general hospital.
    Pisetta LM; Tonin FZ; Akiyoshi FK; Santos FA; Fernandes D
    Int J Qual Health Care; 2024 Sep; 36(3):. PubMed ID: 39215969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
    Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
    BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
    Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
    J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.